Literature DB >> 7091299

Generation of a complement-derived chemotactic factor for tumor cells in experimentally induced peritoneal exudates and its effect on the local metastasis of circulating tumor cells.

F W Orr, S Mokashi, J Delikatny.   

Abstract

A chemotactic factor for tumor cells was found in inflammatory exudate fluids induced by giving intraperitoneal injections of glycogen to Sprague-Dawley rats. The quantity of chemotactic activity and the period of time during which it could be detected correlated with the inflammatory reaction, measured by the cellular composition of the exudates and their content of protein and lysosomal enzymes. In gel filtration the chemotactic factor behaved mainly as a molecule having a molecular weight of approximately 6000 daltons. Its biologic activity was blocked by antiserums directed against C5 but not by antiserums against C3 or C4. In these two respects, the factor generated in vivo has the same properties as a previously described chemotactic factor that can be generated in vitro by proteolysis of purified C5 or C5a. Chemotactic activity was not detected in the glycogen-induced peritoneal exudates of rats depleted of serum complement by cobra venom factor. Intravenously injected Walker tumor cells arrested and formed metastases in the mesenteries of rats with peritonitis in greater numbers than in normal controls, animals depleted of complement during the experimental period, or animals given intraperitoneal injections of the vasopermeability agent, histamine. The growth of tumor cells in vitro was not promoted by peritoneal exudate fluids, nor was the number of metastases on vivo greater than in negative controls, in animals in which peritonitis was induced 24 hours after the intravenous injection of tumor cells. It is argued that chemotactic mechanisms can contribute to the formation of metastases at sites of tissue injury.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7091299      PMCID: PMC1916031     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  20 in total

1.  A unique complement derived chemotactic factor for tumor cells.

Authors:  A G Romualdez; P A Ward
Journal:  Proc Natl Acad Sci U S A       Date:  1975-10       Impact factor: 11.205

2.  Surface biochemical changes accompanying primary infection with Rous sarcoma virus. II. Proteolytic and glycosidase activity and sublethal autolysis.

Authors:  H B Bosmann; T Lockwood; H R Morgan
Journal:  Exp Cell Res       Date:  1974-01       Impact factor: 3.905

3.  Studies on the mechanisms of invasion in cancer. II. In vivo effects of a factor chemotactic for cancer cells.

Authors:  T Ozaki; K Yoshida; K Ushijima; H Hayashi
Journal:  Int J Cancer       Date:  1971-01-15       Impact factor: 7.396

4.  Chemotactic factor associated with invasion of cancer cells.

Authors:  H Hayashi; K Yoshida; T Ozaki; K Ushijima
Journal:  Nature       Date:  1970-04-11       Impact factor: 49.962

5.  Depletion of plasma complement in vivo by a protein of cobra venom: its effect on various immunologic reactions.

Authors:  C G Cochrane; H J Müller-Eberhard; B S Aikin
Journal:  J Immunol       Date:  1970-07       Impact factor: 5.422

6.  Chemotactic responses of tumor cells to products of resorbing bone.

Authors:  W Orr; J Varani; M K Gondex; P A Ward; G R Mundy
Journal:  Science       Date:  1979-01-12       Impact factor: 47.728

Review 7.  Acute inflammation. A review.

Authors:  G B Ryan; G Majno
Journal:  Am J Pathol       Date:  1977-01       Impact factor: 4.307

8.  Trauma and the localization of tumor cells.

Authors:  B Fisher; E R Fisher; N Feduska
Journal:  Cancer       Date:  1967-01       Impact factor: 6.860

9.  Characteristics of the chemotactic response of neoplastic cells to a factor derived from the fifth component of complement.

Authors:  W Orr; J Varani; P A Ward
Journal:  Am J Pathol       Date:  1978-11       Impact factor: 4.307

10.  Complement-derived leukotactic factors in inflammatory synovial fluids of humans.

Authors:  P A Ward; N J Zvaifler
Journal:  J Clin Invest       Date:  1971-03       Impact factor: 14.808

View more
  7 in total

Review 1.  [Importance of fibroblast chemotaxis in wound healing and tumor cell evasion].

Authors:  H Mensing
Journal:  Klin Wochenschr       Date:  1985-02-15

2.  Stimulation of human prostatic carcinoma cell growth by factors present in human bone marrow.

Authors:  M Chackal-Roy; C Niemeyer; M Moore; B R Zetter
Journal:  J Clin Invest       Date:  1989-07       Impact factor: 14.808

Review 3.  Interactions between cancer cells and the microvasculature: a rate-regulator for metastasis.

Authors:  L Weiss; F W Orr; K V Honn
Journal:  Clin Exp Metastasis       Date:  1989 Mar-Apr       Impact factor: 5.150

Review 4.  Adhesion molecules and their role in cancer metastasis.

Authors:  R M Lafrenie; M R Buchanan; F W Orr
Journal:  Cell Biophys       Date:  1993 Aug-Dec

5.  Detection of a complement-derived chemotactic factor for tumor cells in human inflammatory and neoplastic effusions.

Authors:  F W Orr; E J Delikatny; S Mokashi; G V Krepart; H G Stiver
Journal:  Am J Pathol       Date:  1983-01       Impact factor: 4.307

6.  The effects of oxygen radical--mediated pulmonary endothelial damage on cancer metastasis.

Authors:  F W Orr; I Y Adamson; D Warner; V Leroyer; L Werner; S Shaughnessy; L Young
Journal:  Mol Cell Biochem       Date:  1988-12       Impact factor: 3.396

7.  Invasion and metastasis.

Authors:  I Carr; F W Orr
Journal:  Can Med Assoc J       Date:  1983-05-15       Impact factor: 8.262

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.